N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine

C105H95FN30O3S2 — CID 159809335

IUPACN-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine
SMILESCCc1cnn(Nc2cc(CN(C)C)nc(-c3cccs3)n2)c1.CN(C)CCOc1ccc2c(Nn3ncc4ccccc43)nc(Oc3ccc(C#N)cc3)nc2c1.Cc1cc(Nn2cc(C3CC3)cn2)nc(OCc2cccc(F)c2)n1.Cc1cccc(-c2cc(Nn3ncc4ccccc43)nc(Cc3ccc4ncsc4c3)n2)c1.c1ccc(-c2nc(Nn3ncc4ccccc43)c3[nH]ccc3n2)cc1
InChIInChI=1S/C26H23N7O2.C26H20N6S.C19H14N6.C18H18FN5O.C16H20N6S/c1-32(2)13-14-34-21-11-12-22-23(15-21)29-26(35-20-9-7-18(16-27)8-10-20)30-25(22)31-33-24-6-4-3-5-19(24)17-28-33;1-17-5-4-7-19(11-17)22-14-26(31-32-23-8-3-2-6-20(23)15-28-32)30-25(29-22)13-18-9-10-21-24(12-18)33-16-27-21;1-2-6-13(7-3-1)18-22-15-10-11-20-17(15)19(23-18)24-25-16-9-5-4-8-14(16)12-21-25;1-12-7-17(23-24-10-15(9-20-24)14-5-6-14)22-18(21-12)25-11-13-3-2-4-16(19)8-13;1-4-12-9-17-22(10-12)20-15-8-13(11-21(2)3)18-16(19-15)14-6-5-7-23-14/h3-12,15,17H,13-14H2,1-2H3,(H,29,30,31);2-12,14-16H,13H2,1H3,(H,29,30,31);1-12,20H,(H,22,23,24);2-4,7-10,14H,5-6,11H2,1H3,(H,21,22,23);5-10H,4,11H2,1-3H3,(H,18,19,20)
InChIKeyNKUXZIFBPANRLD-UHFFFAOYSA-N
MW1908.25 g/mol
LogP20.54
Rot. Bonds28

About N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine

N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine (PubChem CID 159809335) has the molecular formula C105H95FN30O3S2 and a molecular weight of 1908.25 g/mol. Its IUPAC name is N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine.

Molecular Properties

Compound NameN-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine
PubChem CID159809335
Molecular FormulaC105H95FN30O3S2
Molecular Weight1908.25 g/mol
Exact Mass1906.76
IUPAC NameN-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine
SMILESCCc1cnn(Nc2cc(CN(C)C)nc(-c3cccs3)n2)c1.CN(C)CCOc1ccc2c(Nn3ncc4ccccc43)nc(Oc3ccc(C#N)cc3)nc2c1.Cc1cc(Nn2cc(C3CC3)cn2)nc(OCc2cccc(F)c2)n1.Cc1cccc(-c2cc(Nn3ncc4ccccc43)nc(Cc3ccc4ncsc4c3)n2)c1.c1ccc(-c2nc(Nn3ncc4ccccc43)c3[nH]ccc3n2)cc1
InChIInChI=1S/C26H23N7O2.C26H20N6S.C19H14N6.C18H18FN5O.C16H20N6S/c1-32(2)13-14-34-21-11-12-22-23(15-21)29-26(35-20-9-7-18(16-27)8-10-20)30-25(22)31-33-24-6-4-3-5-19(24)17-28-33;1-17-5-4-7-19(11-17)22-14-26(31-32-23-8-3-2-6-20(23)15-28-32)30-25(29-22)13-18-9-10-21-24(12-18)33-16-27-21;1-2-6-13(7-3-1)18-22-15-10-11-20-17(15)19(23-18)24-25-16-9-5-4-8-14(16)12-21-25;1-12-7-17(23-24-10-15(9-20-24)14-5-6-14)22-18(21-12)25-11-13-3-2-4-16(19)8-13;1-4-12-9-17-22(10-12)20-15-8-13(11-21(2)3)18-16(19-15)14-6-5-7-23-14/h3-12,15,17H,13-14H2,1-2H3,(H,29,30,31);2-12,14-16H,13H2,1H3,(H,29,30,31);1-12,20H,(H,22,23,24);2-4,7-10,14H,5-6,11H2,1H3,(H,21,22,23);5-10H,4,11H2,1-3H3,(H,18,19,20)
InChIKeyNKUXZIFBPANRLD-UHFFFAOYSA-N
XLogP20.54
TPSA364.79 Ų
H-Bond Donors6
H-Bond Acceptors34
Rotatable Bonds28
Heavy Atoms141
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001908.25
LogP ≤ 520.54
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1034

Analyze N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine?
The IUPAC name of N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine (CID 159809335) is N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine.
What is the SMILES notation for N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine?
The canonical SMILES for N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine is CCc1cnn(Nc2cc(CN(C)C)nc(-c3cccs3)n2)c1.CN(C)CCOc1ccc2c(Nn3ncc4ccccc43)nc(Oc3ccc(C#N)cc3)nc2c1.Cc1cc(Nn2cc(C3CC3)cn2)nc(OCc2cccc(F)c2)n1.Cc1cccc(-c2cc(Nn3ncc4ccccc43)nc(Cc3ccc4ncsc4c3)n2)c1.c1ccc(-c2nc(Nn3ncc4ccccc43)c3[nH]ccc3n2)cc1.
What is the InChIKey of N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine?
The InChIKey is NKUXZIFBPANRLD-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H23N7O2.C26H20N6S.C19H14N6.C18H18FN5O.C16H20N6S/c1-32(2)13-14-34-21-11-12-22-23(15-21)29-26(35-20-9-7-18(16-27)8-10-20)30-25(22)31-33-24-6-4-3-5-19(24)17-28-33;1-17-5-4-7-19(11-17)22-14-26(31-32-23-8-3-2-6-20(23)15-28-32)30-25(29-22)13-18-9-10-21-24(12-18)33-16-27-21;1-2-6-13(7-3-1)18-22-15-10-11-20-17(15)19(23-18)24-25-16-9-5-4-8-14(16)12-21-25;1-12-7-17(23-24-10-15(9-20-24)14-5-6-14)22-18(21-12)25-11-13-3-2-4-16(19)8-13;1-4-12-9-17-22(10-12)20-15-8-13(11-21(2)3)18-16(19-15)14-6-5-7-23-14/h3-12,15,17H,13-14H2,1-2H3,(H,29,30,31);2-12,14-16H,13H2,1H3,(H,29,30,31);1-12,20H,(H,22,23,24);2-4,7-10,14H,5-6,11H2,1H3,(H,21,22,23);5-10H,4,11H2,1-3H3,(H,18,19,20).
What are the key properties of N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine?
N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine has a molecular weight of 1908.25 g/mol, XLogP of 20.54, 28 rotatable bonds, 6 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(1,3-benzothiazol-6-ylmethyl)-6-(3-methylphenyl)pyrimidin-4-yl]indazol-1-amine;N-(4-cyclopropylpyrazol-1-yl)-2-[(3-fluorophenyl)methoxy]-6-methylpyrimidin-4-amine;4-[7-[2-(dimethylamino)ethoxy]-4-(indazol-1-ylamino)quinazolin-2-yl]oxybenzonitrile;6-[(dimethylamino)methyl]-N-(4-ethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine;N-indazol-1-yl-2-phenyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine is sourced from PubChem (CID 159809335), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).